Showing results (151-160 of 3,126) with videos related to

Sort By:
Pageof 313
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2021
Probiotics for the Chemoprotective Role against the Toxic Effect of Cancer ChemotherapyAafrin Waziri, Charu Bharti, Mohammed Aslam, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 6, 2021
Dehydrocostus Lactone Induces Apoptosis and Cell Cycle Arrest through Regulation of JAK2/STAT3/PLK1 Signaling Pathway in Human Esophageal Squamous Cell Carcinoma CellsGanghua Yang, Binwu Sheng, Ruixiang Li, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 6, 2021
Formulation and Evaluation of Isradipine Nanosuspension and Exploring its Role as a Potential Anticancer Drug by Computational ApproachPrasanta Kumar Mohapatra, Rajnish Srivastava, Krishna Kumar Varshney, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 5, 2021
Pharmacological Basis of Breast Cancer Resistance to Therapies - An OverviewStefania Crucitta, Federico Cucchiara, Francesca Sciandra, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 23, 2023
Application of Polymer Materials in Targeting GliomaJia Guo, Zheng Yao, Feiyu Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 3, 2023
Coumarin and Piperazine Conjugates as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII IsoformsAaftaab Sethi, Sharon Munagalasetty, Mohammed Arifuddin, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 3, 2016
Novel [1,2,4] Triazol [4,3-a] Pyridine Derivatives as Potential Selective c-Met Inhibitors with Improved Pharmacokinetic PropertiesJunjun Zhao, Shaohua Gou, Xiaobing Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 31, 2017
Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in CancerYunqian Wang, Yingxuan Chen, Jingyuan Fang
Anti-Cancer Agents in Medicinal Chemistry|March 31, 2017
Body Fluids-Derived Exosomes: Paving the Novel Road to Lung Cancer Diagnosis and TherapyYu Sun, Lin Li, Liang Wang, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 31, 2017
ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell Lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT PathwayHua Yang, Pengcheng Ma, Yuping Cao, et al.
Pageof 313